pre230109 和记黄埔.pdf

1、STRONG INNOVATION&COMMERCIALIZATION BUILDING VALUE&SUSTAINABILITYCORPORATE PRESENTATIONJanuary 2023Nasdaq/AIM:HCM|HKEX:131GET PDFThe performance and results of operations of the HUTCHMED Group contained within this presentation are historical in nature,and past performance is no guarantee of future

2、results.This presentation contains forward-looking statements within the meaning of the“safe harbor”provisions of the U.S.Private Securities Litigation Reform Act of 1995.These forward-looking statements can be identified by words like“will,”“expects,”“anticipates,”“future,”“intends,”“plans,”“believ

3、es,”“estimates,”“pipeline,”“could,”“potential,”“first-in-class,”“best-in-class,”“designed to,”“objective,”“guidance,”“pursue,”or similar terms,or by express or implied discussions regarding potential drug candidates,potential indications for drug candidates or by discussions of strategy,plans,expect

4、ations or intentions.You should not place undue reliance on these statements.Such forward-looking statements are based on the current beliefs and expectations of management regarding future events,and are subject to significant known and unknown risks and uncertainties.Should one or more of these ri

5、sks or uncertainties materialize,or should underlying assumptions prove incorrect,actual results may vary materially from those set forth in the forward-looking statements.There can be no guarantee that any of our drug candidates will be approved for sale in any market,that any approvals which are o

6、btained will be obtained at any particular time,or that the sales of products marketed or otherwise commercialized by HUTCHMED and/or its collaboration partners(collectively,“HUTCHMEDS Products”)will achieve any particular revenue or net income levels.In particular,managements expectations could be